Arita Hideyuki, Ikawa Toshiki, Kanayama Naoyuki, Morimoto Masahiro, Umehara Toru, Yoshizawa Hidenori, Kodama Yoshinori, Okita Yoshiko, Kinoshita Manabu, Konishi Koji
Department of Neurosurgery, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Acta Neurochir (Wien). 2025 Jun 5;167(1):163. doi: 10.1007/s00701-025-06578-5.
Recent advances in cancer treatment have prolonged survival after the onset of brain metastasis (BM), increasing the incidence of local progression (LP) following radiotherapy. However, no standard approach exists for managing LP. We aimed to evaluate the outcomes of salvage surgery in a clinical setting.
The clinical data were retrospectively collected from the medical records of 49 patients who underwent their first salvage surgery for LP of BM at a single institution between April 2014 and March 2024. Overall survival (OS) and LP-free survival (LPFS) were evaluated using the Kaplan-Meier method.
Most patients (47/49, 96%) had a history of stereotactic radiosurgery (n = 34) and/or stereotactic radiotherapy (n = 14). The histopathological examination of surgical specimens confirmed tumor recurrence in 33 patients and radiation necrosis (RN) in 16 patients. The interval from prior radiotherapy to salvage surgery was longer in patients with RN than in those with recurrence (median: 42.3 vs. 9.3 months, respectively). OS was longer in the RN group compared with the recurrent group (median: 68.5 months and 21.8 months, respectively). In the recurrent group, shorter OS was associated with preoperative poor KPS (< 70), the presence of active extracranial lesions, and RPA classes 2-3. The extent of resection, postoperative chemotherapy, and local irradiation had no significant effect on OS. After salvage surgery, further LP was observed in 20 patients (61%), with a median LPFS of 7.0 months in the recurrent group. No significant association was found between LPFS and the extent of tumor removal, postoperative chemotherapy, and RT.
This study highlights a relatively prolonged survival period following salvage surgery for local progression of BM after irradiation. Salvage surgery is a treatment option in patients with good extracranial control and performance status. The high recurrence rate following salvage treatment underscores the need for developing additional treatment approaches.
癌症治疗的最新进展延长了脑转移(BM)发生后的生存期,增加了放疗后局部进展(LP)的发生率。然而,目前尚无管理LP的标准方法。我们旨在评估临床环境中挽救性手术的结果。
回顾性收集了2014年4月至2024年3月期间在单一机构接受首次BM-LP挽救性手术的49例患者的病历资料。采用Kaplan-Meier法评估总生存期(OS)和无局部进展生存期(LPFS)。
大多数患者(47/49,96%)有立体定向放射外科手术史(n = 34)和/或立体定向放射治疗史(n = 14)。手术标本的组织病理学检查证实33例为肿瘤复发,16例为放射性坏死(RN)。RN患者从先前放疗到挽救性手术的间隔时间比复发患者更长(中位数:分别为42.3个月和9.3个月)。RN组的OS比复发组更长(中位数:分别为68.5个月和21.8个月)。在复发组中,较短的OS与术前KPS差(<70)、存在活跃的颅外病变以及RPA 2-3级有关。切除范围、术后化疗和局部放疗对OS无显著影响。挽救性手术后,20例患者(61%)出现进一步LP,复发组的中位LPFS为7.0个月。LPFS与肿瘤切除范围、术后化疗和放疗之间未发现显著关联。
本研究强调了放疗后BM局部进展的挽救性手术后生存期相对延长。挽救性手术是颅外控制良好且身体状况良好的患者的一种治疗选择。挽救性治疗后的高复发率凸显了开发其他治疗方法的必要性。